HIGHLIGHTS
- who: Michael A. Kiebish and colleagues from the Center for Medicines Discovery, Nuffield Department of Medicine, University of Oxford, Oxford OX3, UK have published the research work: Bayesian Model Infers Drug Repurposing Candidates for Treatment of COVID-19, in the Journal: (JOURNAL) of 11/03/2020
- what: The approach described herein largely complements artificial_intelligence (AI) tools and algorithms that have been mobilized during this emerging health crisis. Data source for this study was as described by Bojkova et_al where the concentrations of SARS-CoV-2 titer in the supernatant at 2 h, 6 h, 10 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.